Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kui Yu

Showing results (261-270 of 264) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 264 results.
BMC Cancer|April 16, 2020
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)Hai-Bo Sun, Wen-Qun Xing, Xian-Ben Liu, et al.
Annals of Surgical Oncology|November 18, 2024
Multimodality Therapy and Survival Outcomes in Resectable Primary Small Cell Carcinoma of the Esophagus: A Multicenter Retrospective StudyLei Xu, Yu-Shang Yang, Bin Li, et al.
Annals of Translational Medicine|February 8, 2021
A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909)Yan Zheng, Xian-Ben Liu, Hai-Bo Sun, et al.
Journal of Hepatology|December 21, 2020
Association of liver abnormalities with in-hospital mortality in patients with COVID-19Ze-Yang Ding, Gan-Xun Li, Lin Chen, et al.
Pageof 27

Showing results (261-270 of 264) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 264 results.
BMC Cancer|April 16, 2020
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)Hai-Bo Sun, Wen-Qun Xing, Xian-Ben Liu, et al.
Annals of Surgical Oncology|November 18, 2024
Multimodality Therapy and Survival Outcomes in Resectable Primary Small Cell Carcinoma of the Esophagus: A Multicenter Retrospective StudyLei Xu, Yu-Shang Yang, Bin Li, et al.
Annals of Translational Medicine|February 8, 2021
A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909)Yan Zheng, Xian-Ben Liu, Hai-Bo Sun, et al.
Journal of Hepatology|December 21, 2020
Association of liver abnormalities with in-hospital mortality in patients with COVID-19Ze-Yang Ding, Gan-Xun Li, Lin Chen, et al.
Pageof 27